NF-κB, Mesenchymal Differentiation and Glioblastoma

by Bakhtiar Yamini
Published 2018-08-01

An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma

by Seán B. Lyne, Bakhtiar Yamini
Published 2021-04-01

p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability

by Longtao Wu, Clayton D. Crawley, Andrea Garofalo, Jackie W. Nichols, Paige-Ashley Campbell, Galina F. Khramtsova, Olufunmilayo I. Olopade, Ralph R. Weichselbaum, Bakhtiar Yamini
Published 2020-10-01

CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma

by David J. Voce, Giovanna M. Bernal, Kirk E. Cahill, Longtao Wu, Nassir Mansour, Clayton D. Crawley, Paige-Ashley S. Campbell, Ainhoa Arina, Ralph R. Weichselbaum, Bakhtiar Yamini
Published 2021-03-01

DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy

by Szymon J. Szymura, Giovanna M. Bernal, Longtao Wu, Zhongqin Zhang, Clayton D. Crawley, David J. Voce, Paige-Ashley Campbell, Diana E. Ranoa, Ralph R. Weichselbaum, Bakhtiar Yamini
Published 2020-03-01